A novel class of difluorinated cyclopropanoic nucleoside analogues containing a propyl spacer between the cyclopropane ring and the heterocycle has been prepared. Some of these compounds showed weak antitumor activity in prelimary screenings. The resolution of these racemic compounds on an analytical scale was performed by HPLC using chiral stationary phases.